Ticker Scorecard - ABUS Basics Company: Arbutus Biopharma Corporation IPO Date: October 31, 2008 Sector: Healthcare Industry: Biotech Market Cap: $602.58M Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 3.35% Avg Daily Range (30 D): $0.08 | 2.33% Avg Daily Range (90 D): $0.07 | 1.96% Institutional Daily Volume Avg Daily Volume: 1.18M Avg Daily Volume (30 D): .68M Avg Daily Volume (90 D): .76M Trade Size Avg Trade Size (Sh.): 224 Avg Trade Size (Sh.) (30 D): 108 Avg Trade Size (Sh.) (90 D): 113 Institutional Trades Total Inst.Trades: 207 Avg Inst. Trade: $1.76M Avg Inst. Trade (30 D): $1.06M Avg Inst. Trade (90 D): $1.79M Avg Inst. Trade Volume: .51M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.44M Avg Closing Trade (30 D): $1.4M Avg Closing Trade (90 D): $2.51M Avg Closing Volume: 684.29K     News Jun 13, 2024 @ 9:12 AM Ultragenyx (RARE) Moves 7.8% Higher: Will This Str... Source: Zacks Equity Research Jun 6, 2024 @ 3:15 PM Treatment with Arbutus’ Imdusiran and VTP-3... Source: Arbutus Biopharma Corporation Jun 5, 2024 @ 6:30 AM Arbutus’ Imdusiran with Short Course Interf... Source: Arbutus Biopharma Corporation May 29, 2024 @ 11:30 AM Arbutus to Participate in Jefferies Global Healthc... Source: Arbutus Biopharma Corporation May 22, 2024 @ 6:00 AM Arbutus to Present Imdusiran Data at EASL Congress... Source: Arbutus Biopharma Corporation Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.43 $-.1 $-.11 Diluted EPS $-.43 $-.1 $-.11 Revenue $ 6.74M $ 1.34M $ 1.73M Gross Profit $ $ $ Net Income / Loss $ -76.7M $ -19.72M $ -19.8M Operating Income / Loss $ -83.13M $ -21.44M $ -21.58M Cost of Revenue $ $ $ Net Cash Flow $ 14.32M $ -30.94M $ 19.69M PE Ratio     Splits Nov 04, 2010:   5:1